Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemiaAlessandra Tedeschi, Francesca Ricci, Maria Cecilia Goldaniga, et al.
British Journal of Haematology|January 8, 2025
Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantationFrancesca Perutelli, Elia Boccellato, Maria Chiara Montalbano, et al.
American Journal of Hematology|March 16, 2017
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphomaFrancesca Romana Mauro, Piero Galieni, Alessandra Tedeschi, et al.
American Journal of Hematology|August 6, 2019
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) networkMarzia Varettoni, Emanuela Boveri, Silvia Zibellini, et al.
The Lancet. Oncology|September 13, 2024
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trialAlessandra Tedeschi, Anna Maria Frustaci, Adalgisa Condoluci, et al.
Leukemia & Lymphoma|February 5, 2015
Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemiaAlessandra Tedeschi, Paola Picardi, Simone Ferrero, et al.
American Journal of Hematology|March 10, 2025
Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom MacroglobulinemiaJonas Paludo, Jithma P Abeykoon, Nirosha D Perera, et al.
British Journal of Haematology|March 9, 2026
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre studyNicolò Danesin, Francesco Autore, Anna Maria Frustaci, et al.
Therapeutic Advances in Hematology|October 17, 2022
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemiaAnna Maria Frustaci, Giovanni Del Poeta, Andrea Visentin, et al.
Cancers|June 29, 2019
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12Francesco Autore, Paolo Strati, Idanna Innocenti, et al.
Pageof 5